45 related articles for article (PubMed ID: 30229820)
1. The increase of miR-27a affects the role of cisplatin on proliferation and migration capacities of liver cancer cells.
Li W; Yu ZX; Ma BF
Eur Rev Med Pharmacol Sci; 2018 Sep; 22(17):5490-5498. PubMed ID: 30229820
[TBL] [Abstract][Full Text] [Related]
2. Bmi-1-induced miR-27a and miR-155 promote tumor metastasis and chemoresistance by targeting RKIP in gastric cancer.
Li Y; Tian Z; Tan Y; Lian G; Chen S; Chen S; Li J; Li X; Huang K; Chen Y
Mol Cancer; 2020 Jun; 19(1):109. PubMed ID: 32580736
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of microRNA-9 enhances cisplatin sensitivity in hepatocellular carcinoma by regulating EIF5A2-mediated epithelial-mesenchymal transition.
Bao Y; Zhang Y; Lu Y; Guo H; Dong Z; Chen Q; Zhang X; Shen W; Chen W; Wang X
Int J Biol Sci; 2020; 16(5):827-837. PubMed ID: 32071552
[TBL] [Abstract][Full Text] [Related]
4. miR-203a-A multifaceted regulator modulating cancer hallmarks and therapy response.
Biswal P; Lalruatfela A; Behera SK; Biswal S; Mallick B
IUBMB Life; 2024 Mar; 76(3):108-124. PubMed ID: 37792370
[TBL] [Abstract][Full Text] [Related]
5. EXPRESSION PROFILE OF miR-145, -182, -21, -27a, -29b, and -34a IN BREAST CANCER PATIENTS OF YOUNG AGE.
Chekhun V; Borikun T; Mushii O; Zadvornyi T; Martyniuk О; Kashuba E; Bazas V; Hrybach S; Krotevych M; Lyalkin S; Lukianova N
Exp Oncol; 2024 Feb; 45(4):421-431. PubMed ID: 38328848
[TBL] [Abstract][Full Text] [Related]
6. Potent inhibition of miR-27a by neomycin-bisbenzimidazole conjugates.
Nahar S; Ranjan N; Ray A; Arya DP; Maiti S
Chem Sci; 2015 Oct; 6(10):5837-5846. PubMed ID: 29861909
[TBL] [Abstract][Full Text] [Related]
7. Retraction: INPP1 up-regulation by miR-27a contributes to the growth, migration and invasion of human cervical cancer.
J Cell Mol Med; 2023 Dec; 27(23):3951. PubMed ID: 37485872
[No Abstract] [Full Text] [Related]
8. Upregulation of GTPBP4 Promotes the Proliferation of Liver Cancer Cells.
Chen J; Zhang J; Zhang Z
J Oncol; 2021; 2021():1049104. PubMed ID: 34712323
[TBL] [Abstract][Full Text] [Related]
9. miR-409 down-regulates Jak-Stat pathway to inhibit progression of liver cancer.
Zhang CS; Lin Y; Sun FB; Gao J; Han B; Li SJ
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):146-154. PubMed ID: 30657556
[TBL] [Abstract][Full Text] [Related]
10. miR‑498 inhibits the growth and metastasis of liver cancer by targeting ZEB2.
Zhang X; Xu X; Ge G; Zang X; Shao M; Zou S; Zhang Y; Mao Z; Zhang J; Mao F; Qian H; Xu W
Oncol Rep; 2019 Mar; 41(3):1638-1648. PubMed ID: 30592286
[TBL] [Abstract][Full Text] [Related]
11. miR-664b-5p Inhibits Hepatocellular Cancer Cell Proliferation Through Targeting Oncogene AKT2.
Li H; Guo D; Zhang Y; Yang S; Zhang R
Cancer Biother Radiopharm; 2020 Oct; 35(8):605-614. PubMed ID: 31967930
[No Abstract] [Full Text] [Related]
12. MicroRNA‑124 negatively regulates chloride intracellular channel 1 to suppress the migration and invasion of liver cancer cells.
Yue X; Cui Y; You Q; Lu Y; Zhang J
Oncol Rep; 2019 Oct; 42(4):1380-1390. PubMed ID: 31364737
[TBL] [Abstract][Full Text] [Related]
13. The inhibition of miR-126 in cell migration and invasion of cervical cancer through regulating ZEB1.
Xu J; Wang H; Wang H; Chen Q; Zhang L; Song C; Zhou Q; Hong Y
Hereditas; 2019; 156():11. PubMed ID: 31007650
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-27a Suppresses the Toxic Action of Mepivacaine on Breast Cancer Cells via Inositol-Requiring Enzyme 1-TNF Receptor-Associated Factor 2.
Fu W; Hu X; Li G; Liu S
Contrast Media Mol Imaging; 2023; 2023():1153034. PubMed ID: 37078000
[TBL] [Abstract][Full Text] [Related]
15. Role of microRNAs in glycolysis in gynecological tumors (Review).
Chen Q; Shen S; Lv N; Tong J
Int J Oncol; 2023 May; 62(5):. PubMed ID: 37052244
[TBL] [Abstract][Full Text] [Related]
16. EMT-associated microRNAs and their roles in cancer stemness and drug resistance.
Pan G; Liu Y; Shang L; Zhou F; Yang S
Cancer Commun (Lond); 2021 Mar; 41(3):199-217. PubMed ID: 33506604
[TBL] [Abstract][Full Text] [Related]
17. MiR-27a Facilitates Breast Cancer Progression via GSK-3β.
Chen H; Zhang Y; Cao X; Mou P
Technol Cancer Res Treat; 2020; 19():1533033820965576. PubMed ID: 33025840
[TBL] [Abstract][Full Text] [Related]
18. Effects of Rapamycin Combined with Cisplatin on Tumor Necrosis Factor TNF-α in MG-63 Cells.
Han TY; Ma B; Hu B; Xiang LB; Liu XW
Cell Transplant; 2020; 29():963689720926153. PubMed ID: 32686984
[TBL] [Abstract][Full Text] [Related]
19. Circulating exosomal microRNAs as potential biomarkers of hepatic injury and inflammation in a murine model of glycogen storage disease type 1a.
Resaz R; Cangelosi D; Morini M; Segalerba D; Mastracci L; Grillo F; Bosco MC; Bottino C; Colombo I; Eva A
Dis Model Mech; 2020 Sep; 13(9):. PubMed ID: 32620541
[TBL] [Abstract][Full Text] [Related]
20. Association of the Epithelial-Mesenchymal Transition (EMT) with Cisplatin Resistance.
Ashrafizadeh M; Zarrabi A; Hushmandi K; Kalantari M; Mohammadinejad R; Javaheri T; Sethi G
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32503307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
